C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/4725 (2006.01) A61P 25/00 (2006.01) A61P 25/06 (2006.01)
Patent
CA 2431545
The present invention provides novel pharmaceutically acceptable salts of the compounds of Formula (I) and Formula (Ia), as well as methods for using the pharmaceutically acceptable salts, and also provides processes for making compounds of Formula (I) and Formula (Ia), or the pharmaceutically acceptable salts thereof. Compounds of formula (I) and formula (Ia) are useful for the treatment of neurological disorders, especially migraine.
L'invention concerne des nouveaux sels acceptables au plan pharmaceutique de composés de formule I et de formule Ia, des procédés d'utilisation desdits sels, ainsi que des procédés de fabrication de composés de formule I et de formule Ia, ou des sels pharmaceutiquement acceptables de ceux-ci. Lesdits composés de formule I et de formule Ia sont utiles pour le traitement de troubles neurologiques, notamment de la migraine.
Khau Vien Van
Letourneau Michael Edward
Martinelli Michael John
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Excitatory amino acid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Excitatory amino acid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Excitatory amino acid receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1974693